Global Polyp Biopsy Market Growth (Status and Outlook) 2023-2029

Global Polyp Biopsy Market Growth (Status and Outlook) 2023-2029

Polyps are abnormal tissue growths that most often look like small, flat bumps or tiny mushroom like stalks. Most polyps are small and less than half an inch wide. Most polyps are benign, meaning they’re noncancerous. But because they are due to abnormal cell growth, they can eventually become malignant, or cancerous. Doctor can help determine if the growth is a polyp by performing a biopsy. This involves taking a small sample of tissue and testing it for the presence of cancerous cells.

LPI (LP Information)' newest research report, the “Polyp Biopsy Industry Forecast” looks at past sales and reviews total world Polyp Biopsy sales in 2022, providing a comprehensive analysis by region and market sector of projected Polyp Biopsy sales for 2023 through 2029. With Polyp Biopsy sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polyp Biopsy industry.

This Insight Report provides a comprehensive analysis of the global Polyp Biopsy landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polyp Biopsy portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polyp Biopsy market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polyp Biopsy and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polyp Biopsy.

The global Polyp Biopsy market size is projected to grow from US$ 1036.7 million in 2022 to US$ 1330.7 million in 2029; it is expected to grow at a CAGR of 3.6% from 2023 to 2029.

The specific type of procedure used to obtain a sample will depend on where the polyp or polyps are located, as well as their size and number. The different procedures include colonoscopy for polyps located in the large bowel, colposcopy for polyps located in the vagina or cervix, eophagogastroduodenoscopy (EGD) for polyps located in the gastrointestinal tract and laryngoscopy for polyps located in the nose, throat, or vocal cords.

This report presents a comprehensive overview, market shares, and growth opportunities of Polyp Biopsy market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Colonoscopy
Colposcopy-Directed Biopsy
Esophagogastroduodenoscopy
Laryngoscopy

Segmentation by application
Hospital
Clinics
Diagnostic Centers
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Angiotech
Cardinal Health
Carefusion Corporation
Cigna
C.R. Bard
Devicor Medical Products
DTR Medical
Hologic
INRAD
Olympus

Please note: The report will take approximately 2 business days to prepare and deliver.